Lanas Healthcare Technology launches with $115m M&A funding to drive global healthtech growth

Backed by TA Associates, the new global healthtech platform aims to accelerate innovation in EHR and digital care solutions worldwide. 

Lanas Healthcare Technology Ltd. (“Lanas”), a new global healthcare technology platform, has officially launched following its acquisition of Clanwilliam Group, a leading provider of electronic health record (EHR) solutions across the UK, Ireland, Australia, and New Zealand.

Backed by global private equity firm TA Associates (“TA”), Lanas launches with annual revenues exceeding $120 million, customers in more than 20 countries, and 19 offices across three continents. The business enters the market with over $115 million in committed M&A funding, marking one of the most significant recent investments in international healthcare technology.

Headquartered in Dublin with a strong operational presence in the UK, Ireland, Australia, and New Zealand, Lanas will focus on acquiring, scaling, and supporting proven healthcare technologies that enable more connected, data-driven, and efficient care delivery. Its strategy combines deep EHR expertise with a long-term commitment to operational excellence and sustainable growth.

The company’s foundation is built on the September 2025 acquisition of Clanwilliam Group, a long-established healthtech provider founded in 1996 by Howard Beggs, who now serves as CEO of Lanas. Clanwilliam has grown from a local Irish company into a multinational group supporting over 1.5 million clinical users across pharmacy, primary and community care, specialist, and care platform markets, with particularly strong adoption in the UK, Ireland, Australia, and New Zealand.

Howard Beggs, Founder and CEO of Lanas, said: “Lanas has launched with Clanwilliam at its foundation, providing immediate scale and a three-decade track record of quality, reliability, and innovation. Our goal is to triple the size of the business through organic growth and targeted acquisitions in our core verticals. We already have an active M&A roadmap and expect further acquisitions to be announced in the months ahead.”

In addition to TA Associates, the launch is supported by Apollo-managed funds, Hayfin Capital Management, and Arcmont Asset Management, who are jointly providing additional capital to fuel the platform’s global expansion.

Lanas’ leadership team and board include TA’s Lovisa Lander and Morgan Seigler, bringing deep experience in scaling international healthcare and technology platforms.

Lovisa Lander, Director at TA, added: “Our mission at Lanas is to ignite healthcare innovation and turn ideas into impact. We’re building a platform that enables healthcare professionals to harness the power of technology in their daily work and supports the next generation of healthtech solutions.”

According to The Business Research Company, the global healthcare technology market was valued at $507 billion in 2024, is projected to reach $588 billion in 2025, and could grow to $1.2 trillion by 2029, a CAGR of approximately 20%. In key markets such as the UK, Ireland, Australia, and New Zealand, investment in digital health continues to accelerate as healthcare systems modernise through interoperability, data integration, and digital-first care delivery.

Lanas’ launch underscores the growing demand for innovative healthcare technologies across these markets, as providers and policymakers seek to enhance efficiency, collaboration, and patient outcomes. By investing in established technologies and supporting continued innovation, Lanas aims to strengthen healthcare delivery and improve outcomes for clinicians and patients worldwide.